test

Alexandra Toohey

@Baker Bros. Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PRLDPrelude Therapeutics Inc.
Recent Activity
0.22%
$20.956M
10.124M shares@ $2.08 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
Increased 123.45%
0.21%
$19.623M
1.227M shares@ $15.99 avg price
NGNENeurogene Inc.
Recent Activity
0.2%
$19.134M
456,015 shares@ $41.96 avg price
PRAXPraxis Precision Medicines, Inc.
Recent Activity
Increased 145.65%
0.2%
$18.591M
323,105 shares@ $57.55 avg price
ALMSAlumis Inc.
Recent Activity
0.18%
$16.688M
1.562M shares@ $10.68 avg price
MRUSMerus N.v.
Recent Activity
0.16%
$14.988M
300,000 shares@ $49.96 avg price
TCRXTscan Therapeutics, Inc.
Recent Activity
0.15%
$13.868M
2.785M shares@ $4.98 avg price
NMRANeumora Therapeutics, Inc.
Recent Activity
0.15%
$13.667M
1.035M shares@ $13.21 avg price
XNCRXencor, Inc.
Recent Activity
Increased 22.92%
0.14%
$13.482M
670,431 shares@ $20.11 avg price
TSVT2seventy Bio, Inc.
Recent Activity
0.13%
$11.788M
2.498M shares@ $4.73 avg price